420 Participants Needed

Partner-Assisted Therapy for PTSD

(COOPERATE Trial)

Recruiting at 3 trial locations
EL
DL
Overseen ByDonald Lemon
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: United States Department of Defense
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

PTSD occurs in up to 17% of post-9/11 US Service Members and is associated with long-term functional impairment, family problems, unemployment, and suicidality. Trauma-focused therapies (TFTs), such as Prolonged Exposure (PE), result in significant relief for many. Yet, TFTs are not equally effective for everyone. An important minority (\~40%) will retain their PTSD diagnoses after treatment, and many discontinue treatment prematurely, especially post-9/11 Service Members. TFTs are also more effective in addressing symptoms than psychosocial functioning. More work is needed to improve the consistency and potency of TFTs. Partnering with significant others may provide a powerful method for helping individuals get more out of their PTSD treatment. Observational research shows that relationship factors can help patients initiate, stay in, and experience greater benefit from PTSD treatment. Veterans that were surveyed experienced greater treatment gains when they shared more about their treatment with loved ones and when loved ones accommodated less for PTSD symptoms. Despite the promise of partner-involved interventions, there is no couples approach to PTSD treatment that has demonstrated superior outcomes to individual-only treatment models (i.e., TFTs). To address this gap, the investigators have completed a series of partner-assisted PTSD treatment studies, leading up the current proposal (Partnered PE, PPE). The investigators found that treatment completion rates were better than routine clinical care, and the treatment led to large improvements in participants' functioning, PTSD symptoms, and romantic functioning. For this proposed study, the primary objective is to conduct a randomized controlled trial (Research Level 3; larger-scale clinical trial) to test the superiority of PPE to standard PE among post 9/11 Veterans. The investigator's primary hypothesis is that PPE will lead to greater improvements in psychosocial functioning than standard PE. Secondary and tertiary aims examine posttreatment clinical outcomes (PTSD, depression) and intimate partner outcomes (relationship functioning, distress, caregiver burden, and psychosocial functioning), as well as examine strategies for PPE implementation. In exploratory aims, the investigators will examine the stability of group differences, treatment completion rates, the role military sexual trauma history, and treatment mechanisms.

Research Team

LM

Laura Meis, PhD

Principal Investigator

University of Minnesota, National Center for PTSD, Minneapolis VA Healthcare System

LM

Leslie Morland, PhD

Principal Investigator

National Center for PTSD; San Diego VA Healthcare System

Eligibility Criteria

This trial is for post-9/11 US Service Members with PTSD. Participants should be willing to involve their partners in the treatment process. The study excludes those who may not fully benefit from partnered therapy or have conditions that could interfere with the effectiveness of the treatments being tested.

Inclusion Criteria

Committed relationship of 6+ months
I have been diagnosed with PTSD.
Post-9/11 Veteran Enrolled in VHA
See 1 more

Exclusion Criteria

Imminent suicidality or homicidality
Severe intimate partner violence in the last 6 months
Partner screens positive for PTSD
See 3 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive Partnered Prolonged Exposure (PPE) or Prolonged Exposure (PE) therapy, with intimate partners attending weekly sessions

12 weeks
Weekly sessions

Follow-up

Participants are monitored for safety and effectiveness after treatment, with assessments at 3 and 6 months posttreatment

6 months
Assessments at 3 and 6 months

Treatment Details

Interventions

  • Partnered Prolonged Exposure (PPE)
  • Prolonged Exposure (PE)
Trial Overview The trial tests Partner-Assisted Prolonged Exposure (PPE) against standard Prolonged Exposure (PE) therapy for PTSD. It aims to see if involving a partner leads to better psychosocial functioning, fewer PTSD symptoms, and improved relationship health compared to individual therapy.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Partnered Prolonged Exposure (PPE)Experimental Treatment1 Intervention
Group II: Prolonged Exposure (PE)Active Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

United States Department of Defense

Lead Sponsor

Trials
940
Recruited
339,000+

Lowcountry Center for Veterans Research

Collaborator

Trials
1
Recruited
300+

Veterans Medical Research Foundation

Collaborator

Trials
46
Recruited
5,100+

Minneapolis Veterans Affairs Medical Center

Collaborator

Trials
77
Recruited
355,000+

San Diego Veterans Healthcare System

Collaborator

Trials
38
Recruited
5,500+

Charleston VA Healthcare System

Collaborator

Arizona Veterans Research and Education Foundation

Collaborator

University of Minnesota

Collaborator

Trials
1,459
Recruited
1,623,000+

VA Palo Alto Health Care System

Collaborator

Trials
97
Recruited
58,500+

Atlanta VA Medical Center

Collaborator

Trials
28
Recruited
69,700+
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security